NCT05373615View on ClinicalTrials.gov

Cefiderocol Plasma Concentrations in Patients Receiving Renal Replacement Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 25, 2022

Primary Completion Date

November 20, 2024

Study Completion Date

November 20, 2024

Conditions
Pharmacokinetics
Interventions
DRUG

Cefiderocol

After receipt of Cefiderocol, blood samples will be collected at various time points to determine the pharmacokinetics of Cefiderocol

Trial Locations (1)

06102

Hartford Hospital, Hartford

All Listed Sponsors
collaborator

Shionogi Inc.

INDUSTRY

lead

Hartford Hospital

OTHER